Integer Holdings Corp ITGR

Latest FY: 2025 Healthcare Medical Devices
Market Price $125.31
Market Cap $4.25B
P/E Ratio 43.36
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑8.0% YoY
$1.85B
3-Yr CAGR: 10.4%
Net Income ↓-14.3% YoY
$102.81M
Net Margin: 5.5%
Free Cash Flow ↑5.3% YoY
$105.12M
FCF Yield: 2.48%
EPS (Diluted) ↓-14.0% YoY
$2.89
Basic: $2.96
Return on Equity Efficiency
5.9%
ROA: 253.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ITGR)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $1,386.8M $378.3M $6.0M $0.19 $105.5M $46.9M
FY 2017 $1,461.9M +5.4% $393.6M $66.7M +1,018.6% $2.09 +1,000.0% $149.4M $102.1M +117.6%
FY 2018 $1,215.0M -16.9% $362.7M $168.0M +151.9% $5.15 +146.4% $167.3M $122.4M +19.9%
FY 2019 $1,258.1M +3.5% $355.0M $96.3M -42.6% $2.92 -43.3% $165.4M $117.2M -4.3%
FY 2020 $1,073.4M -14.7% $285.7M $77.3M -19.8% $2.33 -20.2% $181.3M $134.5M +14.8%
FY 2021 $1,221.1M +13.8% $337.0M $96.8M +25.3% $2.91 +24.9% $156.7M $103.2M -23.3%
FY 2022 $1,376.1M +12.7% $359.0M $66.4M -31.4% $1.99 -31.6% $116.4M $41.7M -59.6%
FY 2023 $1,596.7M +16.0% $418.3M $90.7M +36.6% $2.69 +35.2% $180.2M $60.3M +44.7%
FY 2024 $1,716.6M +7.5% $459.0M $119.9M +32.3% $3.36 +24.9% $205.2M $99.8M +65.7%
FY 2025 $1,853.6M +8.0% $500.4M $102.8M -14.3% $2.89 -14.0% $196.1M $105.1M +5.3%
$

Valuation

Market Price $125.31
Market Cap $4.25B
Enterprise Value $5.41B
P/E Ratio 43.36
P/B Ratio 2.44
FCF Yield 2.48%
Dividend Yield N/A
Shares Outstanding 33,954,800
%

Profitability & Margins

Gross Margin 26.99%
Operating Margin 11.94%
Net Margin 5.55%
Return on Equity (ROE) 5.89%
Return on Assets (ROA) 253.40%
Asset Turnover 45.69x
Revenue 3-Yr CAGR 10.44%
🛡️

Financial Health & Liquidity

Current Ratio 0.37
Cash Ratio 0.16
Debt / Equity 0.679
Debt / Assets 29.212
Cash & Equivalents $17.16M
Total Debt $1.19B
Book Value / Share $51.44
💧

Cash Flow Efficiency

Operating Cash Flow $196.15M
Capital Expenditures (CapEx) $91.03M
Free Cash Flow $105.12M
OCF / Revenue 10.58%
FCF / Revenue 5.67%
FCF 3-Yr CAGR 36.15%
🏷️

Per Share Metrics

EPS (Diluted) $2.89
EPS (Basic) $2.96
Dividends / Share N/A
Book Value / Share $51.44
EPS YoY Growth -13.99%
🏛️

Balance Sheet (FY 2025)

Total Assets $40.57M
Total Liabilities $109.81M
Stockholders' Equity $1.75B
Current Assets $40.57M
Current Liabilities $109.81M